netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Fulvestrant found 10 matches
Open monograph to display formulary status BNF Category
  Fulvestrant  (Faslodex®) Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
  Abemaciclib  (Verzenios®) Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
  Alpelisib  (Piqray®) Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
  Palbociclib  (Ibrance®) Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA1063: Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment (08.01.05)
link in drug section NICE TA239: Fulvestrant for the treatment of locally advanced or metastatic breast cancer (08.03.04.01)
link in drug section NICE TA687: Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)
link in drug section NICE TA725: Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)
link in drug section NICE TA816: Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer (08.03.04.01)
link in drug section NICE TA836: Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)


 
netFormulary